Gene · 7033
Papers3,041
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,041
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Thymol Alleviates Colitis by Modulating Intestinal Barrier Damage, Gut Microbiota, and Amino Acid Metabolic Pathways. | J Agric Food Chem | 2025 | 40077957 | PubTator, text mining | PubMed |
| Nephrotoxicity biomarkers following propanil (3,4-dichloropropionanilide) self-poisoning. | Clin Toxicol (Phila) | 2025 | 40034038 | PubTator, text mining | PubMed |
| LETSmix: a spatially informed and learning-based domain adaptation method for cell-type deconvolution in spatial transcriptomics. | Genome Med | 2025 | 40022231 | PubTator, text mining | PubMed |
| TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma. | Commun Med (Lond) | 2025 | 39984660 | PubTator, text mining | PubMed |
| The structural integrity of human TFF1 under reducing conditions. | Redox Biol | 2025 | 39978303 | PubTator, text mining | PubMed |
| Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy. | Cells | 2025 | 39937009 | PubTator, text mining | PubMed |
| Explore the possible influence of Sjogren's syndrome on thyroid cancer: A literature data mining and meta-analysis. | PLoS One | 2025 | 39928612 | PubTator, text mining | PubMed |
| Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma. | Cell Death Dis | 2025 | 39920140 | PubTator, text mining | PubMed |
| Urine biomarkers, acute kidney injury, and fluid overload in neonatal cardiac surgery. | Cardiol Young | 2025 | 39910862 | PubTator, text mining | PubMed |
Roux-en-Y gastric bypass improves liver and glucose homeostasis in Zucker diabetic fatty rats by upregulating hepatic trefoil factor family 3 and activating the phosphatidylinositol 3-kinase/protein kinase B pathway. | Surg Obes Relat Dis | 2025 | 39893149 | PubTator, text mining | PubMed |
| To describe the subsets of malignant epithelial cells in gastric cancer, their developmental trajectories and drug resistance characteristics. | Discov Oncol | 2025 | 39869282 | PubTator, text mining | PubMed |
| Soluble Immune Checkpoint Protein and Lipid Network Associations with All-Cause Mortality Risk: Trans-Omics for Precision Medicine (TOPMed) Program. | medRxiv | 2025 | 39830278 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the unique tumor microenvironment of small cell neuroendocrine cervical carcinoma. | J Transl Med | 2025 | 39762893 | PubTator, text mining | PubMed |
| Causal associations between circulating protein ratios and drug resistance in papillary thyroid cancer: a Mendelian randomization study. | Discov Oncol | 2025 | 39754686 | PubTator, text mining | PubMed |
| A large-scale multi-omics polygenic risk score analysis identified candidate risk locus associated with rheumatoid arthritis. | Joint Bone Spine | 2025 | 39732430 | PubTator, text mining | PubMed |
| TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma. | Oncogene | 2025 | 39658649 | PubTator, text mining | PubMed |
| A bioadhesive antioxidase-overexpressed probiotic prevents radiation enteritis by scavenging the excess reactive oxygen species. | Free Radic Biol Med | 2025 | 39643134 | PubTator, text mining | PubMed |
| Protective effect of Dulaglutide, a GLP1 agonist, on acetic acid-induced ulcerative colitis in rats: involvement of GLP-1, TFF-3, and TGF-β/PI3K/NF-κB signaling pathway. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | 39579211 | PubTator, text mining | PubMed |
Role of Emerging Urinary Biomarkers in Predicting Progressive Deterioration of Kidney Function in Congenital Anomalies of Kidney and Urinary Tract: Trefoil Family Factor 3, Alpha Soluble Klotho and Urinary Microalbuminuria. | J Pediatr Surg | 2025 | 39477750 | PubTator, text mining | PubMed |
| Letter: Answer to "Trefoil Factor-3 and Peripheral Artery Disease: Reason or Result". | Angiology | 2025 | 39187412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7033/papers?page=7